NCT01592227View on ClinicalTrials.gov

A Study to Compare Two Paracetamol Formulations.

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Pain

Interventions

DRUG

Marketed paracetamol

Marketed paracetamol

DRUG

Experimental paracetamol formulation

Experimental paracetamol formulation

Trial Locations (1)

85044

MDS Pharma Services ARIZONA, Phoenix

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01592227 - A Study to Compare Two Paracetamol Formulations. | Biotech Hunter | Biotech Hunter